Vivian Lin

656 total citations
15 papers, 460 citations indexed

About

Vivian Lin is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Molecular Biology. According to data from OpenAlex, Vivian Lin has authored 15 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in Vivian Lin's work include Estrogen and related hormone effects (5 papers), Menopause: Health Impacts and Treatments (5 papers) and Iron Metabolism and Disorders (3 papers). Vivian Lin is often cited by papers focused on Estrogen and related hormone effects (5 papers), Menopause: Health Impacts and Treatments (5 papers) and Iron Metabolism and Disorders (3 papers). Vivian Lin collaborates with scholars based in United States, United Kingdom and Taiwan. Vivian Lin's co-authors include Gloria Bachmann, James A. Simon, Philippe R. Koninckx, David Portman, Steven R. Goldstein, Olavi Ylikorkala, Ajay Gupta, Raymond Pratt, Pharis Mohideen and T. Alp İkizler and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and Clinical Infectious Diseases.

In The Last Decade

Vivian Lin

14 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vivian Lin United States 10 270 183 78 68 64 15 460
Elisabeth Le Nestour France 12 208 0.8× 124 0.7× 37 0.5× 125 1.8× 25 0.4× 18 529
E S Mayall United Kingdom 4 231 0.9× 99 0.5× 92 1.2× 18 0.3× 6 0.1× 6 497
Susana Belli Argentina 11 164 0.6× 73 0.4× 63 0.8× 123 1.8× 8 0.1× 28 515
Luis S. Noble United States 6 57 0.2× 338 1.8× 28 0.4× 791 11.6× 82 1.3× 9 1.1k
Stalo Karageorgi United States 7 32 0.1× 66 0.4× 28 0.4× 58 0.9× 87 1.4× 7 296
G Rumsby United Kingdom 15 200 0.7× 160 0.9× 77 1.0× 22 0.3× 14 0.2× 27 652
Leonardo M. Porchia Mexico 10 109 0.4× 36 0.2× 28 0.4× 53 0.8× 6 0.1× 46 411
Toshihide Masuzawa Japan 7 58 0.2× 134 0.7× 62 0.8× 16 0.2× 14 0.2× 9 467
Maria Alexiadis Australia 16 64 0.2× 126 0.7× 26 0.3× 278 4.1× 15 0.2× 26 570
Silvia Vidal-Millán Mexico 11 45 0.2× 91 0.5× 27 0.3× 6 0.1× 11 0.2× 22 328

Countries citing papers authored by Vivian Lin

Since Specialization
Citations

This map shows the geographic impact of Vivian Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivian Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivian Lin more than expected).

Fields of papers citing papers by Vivian Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vivian Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivian Lin. The network helps show where Vivian Lin may publish in the future.

Co-authorship network of co-authors of Vivian Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Vivian Lin. A scholar is included among the top collaborators of Vivian Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vivian Lin. Vivian Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Auchus, Richard J., Oksana Hamidi, Rosario Pivonello, et al.. (2024). Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia. New England Journal of Medicine. 391(6). 504–514. 18 indexed citations
2.
Smith, David C., Matthias Kroiß, Electron Kebebew, et al.. (2020). A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinoma. Investigational New Drugs. 38(5). 1421–1429. 46 indexed citations
3.
El‐Maouche, Diala, Deborah P. Merke, Maria G. Vogiatzi, et al.. (2020). A Phase 2, Multicenter Study of Nevanimibe for the Treatment of Congenital Adrenal Hyperplasia. The Journal of Clinical Endocrinology & Metabolism. 105(8). 2771–2778. 18 indexed citations
4.
Prague, Julia, Rachel Roberts, Alexander Comninos, et al.. (2019). Neurokinin 3 Receptor Antagonism Rapidly Improves Vasomotor Symptoms With Sustained Duration of Action. Obstetrical & Gynecological Survey. 74(4). 221–222. 1 indexed citations
5.
6.
Prague, Julia, Rachel Roberts, Alexander Comninos, et al.. (2018). Neurokinin 3 receptor antagonism rapidly improves vasomotor symptoms with sustained duration of action. Menopause The Journal of The North American Menopause Society. 25(8). 862–869. 48 indexed citations
7.
8.
Lin, Vivian, et al.. (2015). SODIUM ZIRCONIUM CYCLOSILICATE (ZS-9) FOR HYPERKALEMIA IN STAGE 4/5 CKD SUBGROUP OF THE PHASE 3 HARMONIZE STUDY. American Journal of Kidney Diseases. 65(4). A54–A54. 3 indexed citations
9.
Fishbane, Steven, Ajay Singh, Serge Cournoyer, et al.. (2015). Ferric pyrophosphate citrate (Triferic™) administration via the dialysate maintains hemoglobin and iron balance in chronic hemodialysis patients. Nephrology Dialysis Transplantation. 30(12). 2019–2026. 42 indexed citations
10.
11.
Goldstein, Steven R., Gloria Bachmann, Philippe R. Koninckx, et al.. (2013). Ospemifene 12-month safety and efficacy in postmenopausal women with vulvar and vaginal atrophy. Climacteric. 17(2). 173–182. 98 indexed citations
12.
Simon, James A., et al.. (2012). One-year long-term safety extension study of ospemifene for the treatment of vulvar and vaginal atrophy in postmenopausal women with a uterus. Menopause The Journal of The North American Menopause Society. 20(4). 418–427. 114 indexed citations
13.
Lee, Mon‐Juan, et al.. (2012). Site-Directed Mutations of the Gatekeeping Loop Region Affect the Activity of Escherichia coli Spermidine Synthase. Molecular Biotechnology. 54(2). 572–580. 10 indexed citations
14.
Lin, Vivian & Ronald J. Koenig. (1999). Thyroid hormone receptor coactivators and corepressors. Current Opinion in Endocrinology & Diabetes. 6(4). 287–287. 7 indexed citations
15.
Lin, Vivian, et al.. (1995). Meningococcal Endocarditis Presenting as Cellulitis. Clinical Infectious Diseases. 21(4). 1023–1025. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisabeth Le Nestour Breakdown of academic impact, for papers by E S Mayall Breakdown of academic impact, for papers by Susana Belli Breakdown of academic impact, for papers by Luis S. Noble Breakdown of academic impact, for papers by Stalo Karageorgi Breakdown of academic impact, for papers by G Rumsby Breakdown of academic impact, for papers by Leonardo M. Porchia Breakdown of academic impact, for papers by Toshihide Masuzawa Breakdown of academic impact, for papers by Maria Alexiadis Breakdown of academic impact, for papers by Silvia Vidal-Millán
Rankless by CCL
2026